全球生物可吸收支架市場規模、佔有率、成長分析，依類型（藥物洗脫冠狀動脈支架、西羅莫司洗脫裝置）、依材料（可吸收鎂支架(AMS)、聚合物支架）-產業預測2024-2031

Global Bioresorbable Scaffolds Market Size, Share, Growth Analysis, By Type(Drug Eluting Coronary Scaffolds, Sirolimus-Eluting Device), By Material(Absorbable Magnesium Stent (AMS), Polymeric Scaffold) - Industry Forecast 2024-2031

出版日期: 2024年03月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球生物可吸收支架市場規模為3.7494億美元，預計將從2023年的4.1656億美元成長到2031年的9.6692億美元，在預測期內（2024-2031年）複合年成長率為11.10% 。

由於醫療技術的進步和心血管疾病盛行率的上升，生物可吸收支架市場正在經歷大幅成長。這些支架是用於治療冠狀動脈疾病的臨時植入物，隨著時間的推移逐漸溶解，促進血管自然癒合。市場依材料類型、應用、最終用戶和地區進行分類。基於聚合物的支架由於其生物相容性和逐漸吸收而在材料類型領域佔據主導地位，引領市場。應用領域涵蓋心血管疾病、骨科疾病等，由於發生率高，心血管疾病被視為主要促進因素。最終用戶包括醫院、門診手術中心和專科診所，隨著心臟介入住院人數的增加，增加了支架的需求。從地理位置來看，在完善的醫療基礎設施和不斷增加的心血管病例數量的推動下，北美佔有重要的市場佔有率。歐洲緊隨其後，重點關注研發，而亞太地區則因醫療保健投資增加和人口老化而成長。市場成長促進因素包括老年人口的成長、對微創手術的需求、技術進步。然而，高成本和對熟練專業人員的需求等課題阻礙了市場擴張。正在進行的增強支架性能和功效的研究預計將推動未來生物可吸收支架市場的發展。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Abbott
Medtronic
Boston Scientific Corporation
Biotronik
Elixir Medical Corporation
REVA Medical
Amaranth Medical
Kyoto Medical Planning
Xenogenics Corporation
B. Braun
Cardinal Health
Lombard Medical
Translumina
MicroPort Scientific Corporation
TERUMO CORPORATION

簡介目錄

Product Code: SQMIG35A2472

Global Bioresorbable Scaffolds Market size was valued at USD 374.94 million in 2022 and is poised to grow from USD 416.56 million in 2023 to USD 966.92 million by 2031, growing at a CAGR of 11.10% during the forecast period (2024-2031).

The bioresorbable scaffolds market is experiencing substantial growth attributed to advancements in medical technology and the rising prevalence of cardiovascular diseases. These scaffolds, temporary implants utilized for treating coronary artery diseases, gradually dissolve over time, facilitating natural vessel healing. The market is categorized by material type, application, end-user, and region. Polymer-based scaffolds, dominating the material type segment due to their biocompatibility and gradual resorption, lead the market. The application segment, encompassing cardiovascular diseases, orthopedic disorders, and others, sees cardiovascular diseases as the primary driver due to a high incidence rate. End-users include hospitals, ambulatory surgical centers, and specialized clinics, with increasing hospital admissions for cardiac interventions boosting scaffold demand. Geographically, North America holds a significant market share, driven by well-established healthcare infrastructure and a rising number of cardiovascular cases. Europe follows with a focus on research and development, while the Asia-Pacific region sees growth due to increased healthcare investments and an aging population. Market growth drivers include the growing elderly population, demand for minimally invasive procedures, and technological advancements. However, challenges such as high costs and the need for skilled professionals pose hindrances to market expansion. Ongoing research to enhance scaffold properties and efficacy is expected to drive the bioresorbable scaffolds market in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Scaffolds Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioresorbable Scaffolds Market Segmental Analysis

The Bioresorbable Scaffolds market is segmented on the basis of disease type, treatment, end-user, and regional. Based on Disease Type the market is segmented as, Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO). Based on Treatment the market is segmented as, Anti-vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, And Others. Based on End-user the market is segmented as, Hospital & Clinics, Research and Academics, Others. Based on Regional the market is segmented as, North America, Asia Pacific, Latin America.

Drivers of the Global Bioresorbable Scaffolds Market

The increasing occurrence of cardiovascular diseases, including conditions like coronary artery disease and peripheral artery disease, plays a pivotal role in propelling the bioresorbable scaffolds market forward. To address these ailments and restore proper blood flow, there is a growing need for advanced treatments, fueling the demand for inventive solutions such as bioresorbable scaffolds.

Restraints in the Global Bioresorbable Scaffolds Market

The bioresorbable scaffolds market encounters a hurdle due to the scarcity of extensive long-term clinical data. The effectiveness and safety of bioresorbable scaffold implants relative to traditional stents require additional assessment for a conclusive understanding, emphasizing the need for further evaluation to establish their efficacy and safety over an extended period.

Market Trends of the Global Bioresorbable Scaffolds Market

The growing population of elderly individuals necessitates an increased frequency of healthcare services, leading to a rising demand for bioresorbable scaffolds. This is particularly crucial as older people tend to be more susceptible to cardiovascular diseases, highlighting the importance of advanced medical solutions to address their specific healthcare needs.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bioresorbable Scaffolds Market by Type

Market Overview
Drug Eluting Coronary Scaffolds
Sirolimus-Eluting Device
Everolimus-Eluting Device
Novolimus-Eluting Device
and Paclitaxel-Eluting Device

Global Bioresorbable Scaffolds Market by Material

Market Overview
Absorbable Magnesium Stent (AMS)
Polymeric Scaffold
Polycarbonate Scaffold
and Others

Global Bioresorbable Scaffolds Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elixir Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
REVA Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amaranth Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyoto Medical Planning
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xenogenics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Translumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TERUMO CORPORATION
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments